Literature DB >> 31081439

The Australian drug harms ranking study.

Yvonne Bonomo1, Amanda Norman1, Sam Biondo2, Raimondo Bruno3, Mark Daglish4, Sharon Dawe5, Diana Egerton-Warburton6, Jonathan Karro7, Charles Kim8, Simon Lenton9, Dan I Lubman10, Adam Pastor1, Jill Rundle11, John Ryan12, Paul Gordon13, Patrick Sharry14, David Nutt15, David Castle16.   

Abstract

BACKGROUND/AIM: The aim of the current study was to review drug harms as they occur in Australia using the Multi-criteria Decision Analysis (MCDA) methodology adopted in earlier studies in other jurisdictions.
METHOD: A facilitated workshop with 25 experts from across Australia, was held to score 22 drugs on 16 criteria: 9 related to harms that a drug produces in the individual and 7 to harms to others. Participants were guided by facilitators through the methodology and principles of MCDA. In open discussion, each drug was scored on each criterion. The criteria were then weighted using a process of swing weighting. Scoring was captured in MCDA software tool.
RESULTS: MCDA modelling showed the most harmful substances to users were fentanyls (part score 50), heroin (part score 45) and crystal methamphetamine (part score 42). The most harmful substances to others were alcohol (part score 41), crystal methamphetamine (part score 24) and cigarettes/tobacco (part score 14). Overall, alcohol was the most harmful drug when harm to users and harm to others was combined. A supplementary analysis took into consideration the prevalence of each substance in Australia. Alcohol was again ranked the most harmful substance overall, followed by cigarettes, crystal methamphetamine, cannabis, heroin and pharmaceutical opioids.
CONCLUSIONS: The results of this study make an important contribution to the emerging international picture of drug harms. They highlight the persistent and pervasive harms caused by alcohol. Policy implications and recommendations are discussed. Policies to reduce harm from alcohol and methamphetamine should be a priority.

Entities:  

Keywords:  Alcohol; drugs; harms; illicit drugs; ranking; tobacco

Year:  2019        PMID: 31081439     DOI: 10.1177/0269881119841569

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  14 in total

1.  Associations of Healthcare Service Utilization With Cannabis Use Status, Use Reasons, and Use Characteristics Among Those Age 50 and Older.

Authors:  Namkee G Choi; Diana M DiNitto; C Nathan Marti; Bryan Y Choi
Journal:  J Appl Gerontol       Date:  2022-02-25

2.  Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others-A Perspective of German Addiction Medicine Experts.

Authors:  Udo Bonnet; Michael Specka; Michael Soyka; Thomas Alberti; Stefan Bender; Torsten Grigoleit; Leopold Hermle; Jörg Hilger; Thomas Hillemacher; Thomas Kuhlmann; Jens Kuhn; Christian Luckhaus; Christel Lüdecke; Jens Reimer; Udo Schneider; Welf Schroeder; Markus Stuppe; Gerhard A Wiesbeck; Norbert Wodarz; Heath McAnally; Norbert Scherbaum
Journal:  Front Psychiatry       Date:  2020-10-26       Impact factor: 4.157

Review 3.  A Narrative Review of the Recent 'Ice' Epidemic: An Australian Perspective.

Authors:  Konrad Pisarski
Journal:  Subst Abuse       Date:  2021-04-21

4.  Associations between lifetime classic psychedelic use and markers of physical health.

Authors:  Otto Simonsson; James D Sexton; Peter S Hendricks
Journal:  J Psychopharmacol       Date:  2021-03-09       Impact factor: 4.153

5.  A Personalized Approach Bias Modification Smartphone App ("SWiPE") to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study.

Authors:  Victoria Manning; Hugh Piercy; Joshua Benjamin Bernard Garfield; Stuart Gregory Clark; Mah Noor Andrabi; Dan Ian Lubman
Journal:  JMIR Mhealth Uhealth       Date:  2021-12-10       Impact factor: 4.773

6.  Behavioral economic interactions between cannabis and alcohol purchasing: Associations with disordered use.

Authors:  Sean B Dolan; Tory R Spindle; Ryan Vandrey; Matthew W Johnson
Journal:  Exp Clin Psychopharmacol       Date:  2020-10-01       Impact factor: 3.157

7.  Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.

Authors:  Kate Corrigan; Maeve Haran; Conor McCandliss; Roisin McManus; Shannon Cleary; Rebecca Trant; Yazeed Kelly; Kathryn Ledden; Gavin Rush; Veronica O'Keane; John R Kelly
Journal:  Ir J Med Sci       Date:  2021-06-15       Impact factor: 2.089

8.  Disentangling the effects of cannabis and cigarette smoking on impulsivity.

Authors:  Jason T Round; Therese E Fozard; Amanda A Harrison; Katerina Z Kolokotroni
Journal:  J Psychopharmacol       Date:  2020-06-10       Impact factor: 4.153

9.  Comparison of social and sociodemographic characteristics and treatment goals of persons with alcohol versus drug use disorders: Result from a national census of inpatients in specialized treatment for substance use.

Authors:  Helle Wessel Andersson; Solfrid E Lilleeng; Solveig Osborg Ose
Journal:  Addict Behav Rep       Date:  2021-02-03

10.  The Prevalence and Negative Impacts of Substance Use Disorders among People with HIV in the United States: A Real-Time Delphi Survey of Key Stakeholders.

Authors:  Bryan R Garner; Heather J Gotham; Hannah K Knudsen; Brittany A Zulkiewicz; Stephen J Tueller; Marcus Berzofsky; Tom Donohoe; Erika G Martin; L Lauren Brown; Theodore Gordon
Journal:  AIDS Behav       Date:  2021-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.